Yarui Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yarui Li has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Shuixiang He
Department of Gastroenterology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
4 shared publications Dan Guo
Department of Gastroenterology, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P.R. China
3 shared publicationsGuifang Lu
Department of Gastroenterology, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P.R. China
3 shared publicationsMudan Ren
The First Affiliated Hospital of Xi'an Jiaotong University
3 shared publicationsXinlan Lu
Department of Gastroenterology The First Affiliated Hospital of Xi'an Jiaotong University China
3 shared publicationsJunbi Hu
Department of Gastroenterology, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, P.R. China
2 shared publications
Latest Publications
- 10 June 2022
- Published by Wiley in The FEBS Journal
- Vol. 289 (20) , 6400-6419
The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin
Hematological and neurological expressed 1 (HN1) is closely associated with the proliferation and metastasis of various tumors. However, the physiological functions and clinical significance of HN1 in hepatocellular carcinoma (HCC) remain indistinct. In this study, we investigated the role of HN1 in the pathogenesis of HCC and the underlying mechanism using clinical data from HCC patients, in vitro experiments utilizing HCC cell lines and in vivo animal models. We demonstrated that the overexpressed HN1 in HCC was correlated with patients' adverse outcomes. The gain and loss of function experiments indicated that HN1 could promote the proliferation, migration, and invasion of HCC cells in vitro. Furthermore, we found that HN1 knockdown sensitized HCC cells to oxaliplatin. Mechanically, HN1 prevented HMGB1 protein from ubiquitination and degradation via the autophagy‐lysosome pathway, which was related to the interaction between HN1 protein and TRIM28 protein. In the nucleus, the downregulation of HMGB1 followed by HN1 knockdown resulted in increased DNA damage and cell death in the oxaliplatin‐treated HCC cells. In the cytoplasm, HN1 regulated autophagy via HMGB1. Furthermore, HN1 knockdown in combination with HMGB1 overexpression restored the aggressive phenotypes of HCC cells and the sensitivity of these cells to oxaliplatin. HN1 knockdown inhibited the tumor growth and metastasis, and promoted the anticancer efficiency of oxaliplatin in vivo. In conclusion, our data suggest that the HN1/HMGB1 axis plays an important role in the development/progression and chemotherapy of HCC. Our findings indicate that the HN1/HMGB1 axis may be a promising therapeutic target for HCC treatment.
- 10 June 2022
- Published by Wiley in The FEBS Journal
- Vol. 289 (20) , 6400-6419
The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin
Hematological and neurological expressed 1 (HN1) is closely associated with the proliferation and metastasis of various tumors. However, the physiological functions and clinical significance of HN1 in hepatocellular carcinoma (HCC) remain indistinct. In this study, we investigated the role of HN1 in the pathogenesis of HCC and the underlying mechanism using clinical data from HCC patients, in vitro experiments utilizing HCC cell lines and in vivo animal models. We demonstrated that the overexpressed HN1 in HCC was correlated with patients' adverse outcomes. The gain and loss of function experiments indicated that HN1 could promote the proliferation, migration, and invasion of HCC cells in vitro. Furthermore, we found that HN1 knockdown sensitized HCC cells to oxaliplatin. Mechanically, HN1 prevented HMGB1 protein from ubiquitination and degradation via the autophagy‐lysosome pathway, which was related to the interaction between HN1 protein and TRIM28 protein. In the nucleus, the downregulation of HMGB1 followed by HN1 knockdown resulted in increased DNA damage and cell death in the oxaliplatin‐treated HCC cells. In the cytoplasm, HN1 regulated autophagy via HMGB1. Furthermore, HN1 knockdown in combination with HMGB1 overexpression restored the aggressive phenotypes of HCC cells and the sensitivity of these cells to oxaliplatin. HN1 knockdown inhibited the tumor growth and metastasis, and promoted the anticancer efficiency of oxaliplatin in vivo. In conclusion, our data suggest that the HN1/HMGB1 axis plays an important role in the development/progression and chemotherapy of HCC. Our findings indicate that the HN1/HMGB1 axis may be a promising therapeutic target for HCC treatment.
- Open Access
- 25 March 2022
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 29 (10) , 1373-1383
LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway
The role of long noncoding RNA (lncRNAs) had been demonstrated in different types of cancer, including hepatocellular carcinoma. This study was intended to investigate the role of lncRNA small nucleolar RNA host gene 5 (SNHG5) in HCC proliferation and the liver CSC-like properties. Through functional experiments, we determined that knockdown of SNHG5 repressed HCC cell proliferation and CSC-like properties, while over-expression of SNHG5 promoted cell growth. At the same time, CSC markers (CD44, CD133, and ALDH1) and related transcription factors (OCT4, SOX2, and NANOG) were downregulated when SNHG5 was knocked down. Mechanically, RNA immunoprecipitation (RIP) and RNA pulldown assay showed that SNHG5 regulated the proliferation and CSC-like properties of HCC by binding UPF1. Further investigations showed that expression of critical components of Wnt/β-catenin pathway (β-catenin, TCF4, c-myc, cyclinD1, and c-Jun) were upregulated with depletion of UPF1 in liver CSCs, which were downregulated with depletion of SNHG5. After use of the inhibitor of Wnt/β-catenin pathway, the formation of liver CSCs sphere decreased. Taken together, SNHG5 plays a critical role to promote HCC cell proliferation and cancer stem cell-like properties via UPF1 and Wnt/β-catenin pathway.
- 25 March 2022
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 29 (10) , 1373-1383
Open AccessLncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway
The role of long noncoding RNA (lncRNAs) had been demonstrated in different types of cancer, including hepatocellular carcinoma. This study was intended to investigate the role of lncRNA small nucleolar RNA host gene 5 (SNHG5) in HCC proliferation and the liver CSC-like properties. Through functional experiments, we determined that knockdown of SNHG5 repressed HCC cell proliferation and CSC-like properties, while over-expression of SNHG5 promoted cell growth. At the same time, CSC markers (CD44, CD133, and ALDH1) and related transcription factors (OCT4, SOX2, and NANOG) were downregulated when SNHG5 was knocked down. Mechanically, RNA immunoprecipitation (RIP) and RNA pulldown assay showed that SNHG5 regulated the proliferation and CSC-like properties of HCC by binding UPF1. Further investigations showed that expression of critical components of Wnt/β-catenin pathway (β-catenin, TCF4, c-myc, cyclinD1, and c-Jun) were upregulated with depletion of UPF1 in liver CSCs, which were downregulated with depletion of SNHG5. After use of the inhibitor of Wnt/β-catenin pathway, the formation of liver CSCs sphere decreased. Taken together, SNHG5 plays a critical role to promote HCC cell proliferation and cancer stem cell-like properties via UPF1 and Wnt/β-catenin pathway.
- Open Access
- 19 February 2020
- Published by Springer Nature in Research Square
LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of hepatocellular carcinoma by regulating UPF1 and Wnt signaling pathway
Background: It have been revealed that lncRNAs had a critical role in human cancers, including HCC. Our previous study found a lncRNA SNHG5 related to the development of HCC. However, the role and exact mechanism of SNHG5 in HCC proliferation and the liver CSC-like properties is still unclear. Materials and Methods: We investigated the HCC cells proliferation and CSC-like properties in vitro and in vivo by knockdown or upregulate SNHG5, and detected underlying mechanisms by qRT-PCR, Western blotting, bioinformatic analysis, luciferase reporter assay, RNA immunoprecipitation. Results: Knockdown of SNHG5 repressed HCC cells proliferation and CSC-like properties, while overexpression of SNHG5 promoted cells growth. At the same time, CSCs markers ( CD44, CD133 and ALDH1) and related transcription factors (OCT4, SOX2 and NANOG) were downregulated when SNHG5 knockdown. Further investigations showed that SNHG5 regulated the proliferation and CSC-like properties of HCC by binding UPF1 and regulating Wnt/β-catenin pathway. Conclusions: SNHG5 plays critical role to promote HCC cells proliferation and cancer stem cell-like properties via UPF1 and Wnt/β-catenin pathway.
- 19 February 2020
- Published by Springer Nature in Research Square
Open AccessLncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of hepatocellular carcinoma by regulating UPF1 and Wnt signaling pathway
Background: It have been revealed that lncRNAs had a critical role in human cancers, including HCC. Our previous study found a lncRNA SNHG5 related to the development of HCC. However, the role and exact mechanism of SNHG5 in HCC proliferation and the liver CSC-like properties is still unclear. Materials and Methods: We investigated the HCC cells proliferation and CSC-like properties in vitro and in vivo by knockdown or upregulate SNHG5, and detected underlying mechanisms by qRT-PCR, Western blotting, bioinformatic analysis, luciferase reporter assay, RNA immunoprecipitation. Results: Knockdown of SNHG5 repressed HCC cells proliferation and CSC-like properties, while overexpression of SNHG5 promoted cells growth. At the same time, CSCs markers ( CD44, CD133 and ALDH1) and related transcription factors (OCT4, SOX2 and NANOG) were downregulated when SNHG5 knockdown. Further investigations showed that SNHG5 regulated the proliferation and CSC-like properties of HCC by binding UPF1 and regulating Wnt/β-catenin pathway. Conclusions: SNHG5 plays critical role to promote HCC cells proliferation and cancer stem cell-like properties via UPF1 and Wnt/β-catenin pathway.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 7372868
The Prognosis Analysis of Liver Cirrhosis with Acute Variceal Bleeding and Validation of Current Prognostic Models: A Large Scale Retrospective Cohort Study
Background. Acute variceal bleeding is a major cause of death in liver cirrhosis. This large scale retrospective cohort study aims to analyze the prognosis of patients with cirrhosis and acute variceal bleeding and to validate the current prognostic models. Methods. Patients with cirrhosis and acute variceal bleeding were enrolled from Jan 2019 to March 2020. The independent prognostic factors for in‐hospital death were identified by logistic regression analyses. Area under curves (AUCs) was compared among Child‐Pugh, cirrhosis acute gastrointestinal bleeding (CAGIB) score, and model for end‐stage liver disease (MELD) and neutrophil‐lymphocyte ratio (NLR) scores. Results. Overall, 379 patients with liver cirrhosis and acute variceal bleeding were consecutively evaluated. The majority of the patients were males (59.1%) and the mean age of all patients were 53.7 ± 1.3 years (range 14‐89). Hepatitis B virus (HBV) was the most common underlying cause of liver cirrhosis (54.1%). 72 (19%) patients had hepatocellular carcinoma. Multivariate logistic regression analyses showed that age, HCC, WBC, total serum bilirubin, serum creatinine, and ALT were independently associated with in‐hospital death. And the odds ratios (ORs) for in‐hospital death were 1.066 (95% CI 1.017‐1.118, P = 0.008), 7.19 (95% CI 2.077‐24.893, P = 0.001), 1.123 (95% CI 1.051‐1.201, P = 0.001), 1.014 (95% CI 1.005‐1.023, P = 0.003), 1.012 (95% CI 1.004‐1.021, P = 0.006), and 1.005 (95% CI 1.000‐1.009, P = 0.036), respectively. In the whole cohort with HCC patients, the AUCs of Child‐Pugh, CAGIB, MELD and NLR scores were 0.842 (95% CI 0.801‐0.878), 0.840 (95% CI 0.799‐0.876), 0.798 (95% CI 0.754‐0.838), and 0.688 (95% CI 0.639‐0.735), respectively. The differences were statistically significant between Child‐Pugh and NLR scores (P = 0.0118), and between CAGIB and NLR scores (P = 0.0354). Conclusion. Child‐Pugh and CAGIB scores showed better predictive performance for prognosis of patients with cirrhosis and acute variceal bleeding than NLR scores.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 7372868
Open AccessThe Prognosis Analysis of Liver Cirrhosis with Acute Variceal Bleeding and Validation of Current Prognostic Models: A Large Scale Retrospective Cohort Study
Background. Acute variceal bleeding is a major cause of death in liver cirrhosis. This large scale retrospective cohort study aims to analyze the prognosis of patients with cirrhosis and acute variceal bleeding and to validate the current prognostic models. Methods. Patients with cirrhosis and acute variceal bleeding were enrolled from Jan 2019 to March 2020. The independent prognostic factors for in‐hospital death were identified by logistic regression analyses. Area under curves (AUCs) was compared among Child‐Pugh, cirrhosis acute gastrointestinal bleeding (CAGIB) score, and model for end‐stage liver disease (MELD) and neutrophil‐lymphocyte ratio (NLR) scores. Results. Overall, 379 patients with liver cirrhosis and acute variceal bleeding were consecutively evaluated. The majority of the patients were males (59.1%) and the mean age of all patients were 53.7 ± 1.3 years (range 14‐89). Hepatitis B virus (HBV) was the most common underlying cause of liver cirrhosis (54.1%). 72 (19%) patients had hepatocellular carcinoma. Multivariate logistic regression analyses showed that age, HCC, WBC, total serum bilirubin, serum creatinine, and ALT were independently associated with in‐hospital death. And the odds ratios (ORs) for in‐hospital death were 1.066 (95% CI 1.017‐1.118, P = 0.008), 7.19 (95% CI 2.077‐24.893, P = 0.001), 1.123 (95% CI 1.051‐1.201, P = 0.001), 1.014 (95% CI 1.005‐1.023, P = 0.003), 1.012 (95% CI 1.004‐1.021, P = 0.006), and 1.005 (95% CI 1.000‐1.009, P = 0.036), respectively. In the whole cohort with HCC patients, the AUCs of Child‐Pugh, CAGIB, MELD and NLR scores were 0.842 (95% CI 0.801‐0.878), 0.840 (95% CI 0.799‐0.876), 0.798 (95% CI 0.754‐0.838), and 0.688 (95% CI 0.639‐0.735), respectively. The differences were statistically significant between Child‐Pugh and NLR scores (P = 0.0118), and between CAGIB and NLR scores (P = 0.0354). Conclusion. Child‐Pugh and CAGIB scores showed better predictive performance for prognosis of patients with cirrhosis and acute variceal bleeding than NLR scores.
- Open Access
- 2 July 2019
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 23 (9) , 6271-6282
Long non‐coding RNA SNAI3‐AS1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the UPF1/Smad7 signalling pathway
Emerging evidence has indicated that deregulation of long non‐coding RNAs (lncRNAs) can contribute to the progression of human cancers, including hepatocellular carcinoma (HCC). However, the role and exact mechanism of most lncRNAs in tumours remains largely unknown. In the current study, we found a novel long non‐coding RNA termed SNAI3‐AS1 which was generally up‐regulated in HCC tissues compared with normal control. Higher expression of SNAI3‐AS1 was significantly correlated with shorter overall survival of HCC patients. Knockdown of SNAI3‐AS1 inhibited the proliferation and metastasis of HCC cells in vitro, whereas overexpression of SNAI3‐AS1 promoted the proliferation and metastasis of HCC cells. Further investigations showed that SNAI3‐AS1 could affect HCC tumorigenesis by binding up‐frameshift protein 1 (UPF1), regulating Smad7 expression and activating TGF‐β/Smad pathway. Functionally, SNAI3‐AS1 promoted HCC growth and metastasis by inducing tumour epithelial to mesenchymal transition (EMT). Taken together, these findings showed that SNAI3‐AS1 promotes the progression of HCC by regulating the UPF1 and activating TGF‐β/Smad pathway.
- 2 July 2019
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 23 (9) , 6271-6282
Open AccessLong non‐coding RNA SNAI3‐AS1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the UPF1/Smad7 signalling pathway
Emerging evidence has indicated that deregulation of long non‐coding RNAs (lncRNAs) can contribute to the progression of human cancers, including hepatocellular carcinoma (HCC). However, the role and exact mechanism of most lncRNAs in tumours remains largely unknown. In the current study, we found a novel long non‐coding RNA termed SNAI3‐AS1 which was generally up‐regulated in HCC tissues compared with normal control. Higher expression of SNAI3‐AS1 was significantly correlated with shorter overall survival of HCC patients. Knockdown of SNAI3‐AS1 inhibited the proliferation and metastasis of HCC cells in vitro, whereas overexpression of SNAI3‐AS1 promoted the proliferation and metastasis of HCC cells. Further investigations showed that SNAI3‐AS1 could affect HCC tumorigenesis by binding up‐frameshift protein 1 (UPF1), regulating Smad7 expression and activating TGF‐β/Smad pathway. Functionally, SNAI3‐AS1 promoted HCC growth and metastasis by inducing tumour epithelial to mesenchymal transition (EMT). Taken together, these findings showed that SNAI3‐AS1 promotes the progression of HCC by regulating the UPF1 and activating TGF‐β/Smad pathway.
- Open Access
- 30 April 2019
- Published by Wiley in Cell Proliferation
- Vol. 52 (4) , e12628
DANCR promotes HCC progression and regulates EMT by sponging miR‐27a‐3p via ROCK1/LIMK1/COFILIN1 pathway
Objectives: This research aims to verify that the long non‐coding RNA differentiation antagonizing nonprotein coding RNA (LncRNA DANCR) could modulate the proliferation and metastasis of hepatocellular carcinoma (HCC), and it thus may work as a novel biomarker to render new orientation for early diagnosis and clinical therapy of HCC.Materials and methods: Firstly, qRT‐PCR was used to detect the expression of genes including LncRNA DANCR and miR‐27a‐3p. Next, MTT assay, Ethynyldeoxyuridine (EdU) analysis and clone formation assay were used for investigating cell growth and proliferation. Meanwhile, transwell assay and wound healing assay were applied to evaluate the capacity of cell metastasis and motility, respectively. In addition, bioinformatic analysis and dual‐luciferase reporter assay were applied to analyse molecular interaction. Next, we conducted immunofluorescence and Western blot for mechanic investigation. Last but not the least, xenograft tumours in nude mice were built by subcutaneously injecting Hep3B cells stably transfected with sh‐NC and sh‐DANCR to detect proliferation and SMMC‐7721 cells stably transfected with sh‐NC and sh‐DANCR to investigate metastasis.Results: The results of qRT‐PCR and bioinformatic analysis revealed the high expression of DANCR in HCC. DANCR accelerated proliferation and metastasis of HCC cells and the knockdown of DANCR had the opposite effect. Meanwhile, xenograft tumours in sh‐DANCR group grow slower and have smaller volumes compared with negative control group. Next, the antineoplastic effect of miR‐27a‐3p on cell growth and motility of HCC was confirmed. In addition, we clarified that DANCR acted as a ceRNA to decoy miR‐27a‐3p via mediating ROCK1/LIMK1/COFILIN1 pathway. In the end, we validated that DANCR/miR‐27a‐3p axis regulates EMT progression by cell immunofluorescence and Western blot.Conclusions: In a word, DANCR promotes HCC development and induces EMT by decoying miR‐27a‐3p to regulate ROCK1/LIMK1/COFILIN1 pathway.
- 30 April 2019
- Published by Wiley in Cell Proliferation
- Vol. 52 (4) , e12628
Open AccessDANCR promotes HCC progression and regulates EMT by sponging miR‐27a‐3p via ROCK1/LIMK1/COFILIN1 pathway
Objectives: This research aims to verify that the long non‐coding RNA differentiation antagonizing nonprotein coding RNA (LncRNA DANCR) could modulate the proliferation and metastasis of hepatocellular carcinoma (HCC), and it thus may work as a novel biomarker to render new orientation for early diagnosis and clinical therapy of HCC.Materials and methods: Firstly, qRT‐PCR was used to detect the expression of genes including LncRNA DANCR and miR‐27a‐3p. Next, MTT assay, Ethynyldeoxyuridine (EdU) analysis and clone formation assay were used for investigating cell growth and proliferation. Meanwhile, transwell assay and wound healing assay were applied to evaluate the capacity of cell metastasis and motility, respectively. In addition, bioinformatic analysis and dual‐luciferase reporter assay were applied to analyse molecular interaction. Next, we conducted immunofluorescence and Western blot for mechanic investigation. Last but not the least, xenograft tumours in nude mice were built by subcutaneously injecting Hep3B cells stably transfected with sh‐NC and sh‐DANCR to detect proliferation and SMMC‐7721 cells stably transfected with sh‐NC and sh‐DANCR to investigate metastasis.Results: The results of qRT‐PCR and bioinformatic analysis revealed the high expression of DANCR in HCC. DANCR accelerated proliferation and metastasis of HCC cells and the knockdown of DANCR had the opposite effect. Meanwhile, xenograft tumours in sh‐DANCR group grow slower and have smaller volumes compared with negative control group. Next, the antineoplastic effect of miR‐27a‐3p on cell growth and motility of HCC was confirmed. In addition, we clarified that DANCR acted as a ceRNA to decoy miR‐27a‐3p via mediating ROCK1/LIMK1/COFILIN1 pathway. In the end, we validated that DANCR/miR‐27a‐3p axis regulates EMT progression by cell immunofluorescence and Western blot.Conclusions: In a word, DANCR promotes HCC development and induces EMT by decoying miR‐27a‐3p to regulate ROCK1/LIMK1/COFILIN1 pathway.